Drive Phase PV Limited: Company Profile

Background

Company Overview

Drive Phase PV Limited, established in January 2018, is a UK-based pharmacovigilance consultancy specializing in drug safety services for pharmaceutical companies globally. The company is headquartered in Edgware, Greater London, United Kingdom.

Mission and Vision

Drive Phase PV Limited is dedicated to enhancing patient safety by providing comprehensive pharmacovigilance solutions that support pharmaceutical companies in meeting regulatory requirements and maintaining high safety standards throughout the lifecycle of their products.

Primary Area of Focus

The company's primary focus is on pharmacovigilance consultancy, offering services that ensure the safety and efficacy of pharmaceutical products.

Industry Significance

In the competitive landscape of pharmacovigilance, Drive Phase PV Limited distinguishes itself by offering tailored solutions that help clients navigate complex regulatory environments and uphold patient safety.

Key Strategic Focus

Core Objectives

To provide expert pharmacovigilance services that ensure drug safety and regulatory compliance.

To support pharmaceutical companies in both clinical trials and post-marketing phases.

Specific Areas of Specialization

Pharmacovigilance System Design

Audit and Corrective and Preventive Action (CAPA) Management

Safety Database Management

Safety Data Exchange Agreement (SDEA) Preparation

Key Technologies Utilized

While specific technologies are not detailed in the available sources, pharmacovigilance consultancies typically employ specialized software for safety data management, signal detection, and regulatory reporting.

Primary Markets Targeted

Drive Phase PV Limited primarily serves pharmaceutical companies involved in the development, manufacturing, and marketing of pharmaceutical products, focusing on both clinical trial phases and post-marketing surveillance.

Financials and Funding

Funding History

As of the latest available information, Drive Phase PV Limited has not publicly disclosed details regarding its funding history, total funds raised, or specific funding rounds.

Notable Investors

Information about specific investors is not publicly available.

Intended Utilization of Capital

The company has not publicly disclosed specific plans for the utilization of any raised capital.

Pipeline Development

Key Pipeline Candidates

As a consultancy firm, Drive Phase PV Limited does not develop pharmaceutical products but focuses on providing services to support the development and monitoring of such products by its clients.

Stages of Clinical Trials or Product Development

The company offers services across various stages of pharmaceutical product development, including:

Clinical Trials

Post-Marketing Surveillance

Target Conditions

Drive Phase PV Limited's services are applicable to a wide range of pharmaceutical products, addressing safety and efficacy concerns across various therapeutic areas.

Relevant Timelines for Anticipated Milestones

Specific timelines for milestones are not publicly disclosed.

Technological Platform and Innovation

Proprietary Technologies

While specific proprietary technologies are not detailed in the available sources, pharmacovigilance consultancies typically utilize specialized software platforms for safety data management, signal detection, and regulatory reporting.

Significant Scientific Methods

Signal Detection

Risk Management

Regulatory Compliance Audits

AI-Driven Capabilities

The available sources do not provide information on AI-driven capabilities employed by Drive Phase PV Limited.

Leadership Team

Key Executive Profiles

Thomas Owain Nichols: Director and Consultant. Mr. Nichols has extensive experience in the pharmacovigilance field and serves as the Director of Drive Phase PV Limited.

Competitor Profile

Market Insights and Dynamics

The pharmacovigilance consultancy market is characterized by a growing emphasis on patient safety and regulatory compliance. Companies in this sector offer services that help pharmaceutical firms monitor and manage the safety profiles of their products.

Competitor Analysis

Drive Phase PV Limited operates in a competitive environment with several notable competitors, including:

InSilicoTrials: Provides healthcare simulation services for medical applications worldwide.

Generable: Delivers precision medicine via statistical machine learning models.

CONTINUUM India: Offers pharmacovigilance, regulatory, evidence evaluation, and technology solutions to pharmaceutical firms.

Cognigen: Provides strategic clinical pharmacology and pharmacometric consulting services.

Pharmetheus: Offers pharmacometric services to support efficient and effective drug development processes.

Strategic Collaborations and Partnerships

Specific details regarding strategic collaborations or partnerships for Drive Phase PV Limited are not publicly disclosed.

Operational Insights

Drive Phase PV Limited differentiates itself through its specialized focus on pharmacovigilance consultancy, offering tailored solutions that help clients navigate complex regulatory environments and uphold patient safety.

Strategic Opportunities and Future Directions

The company has the opportunity to expand its service offerings, enhance technological capabilities, and explore new markets to strengthen its position in the pharmacovigilance consultancy sector.